Europe Protein Sequencing Market By Product & Service (Protein Sequencing Products {Reagents & Consumables, Instruments, Software}, Protein Sequencing Services), By Application (Bio-therapeutics, Genetic Engineering, Others), By End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Others), By Country, Competition, Forecast and Opportunities, 2020-2030F

April 2025 | 122 pages | ID: E69B25B98F91EN
TechSci Research

Abstracts

Market Overview

The Europe Protein Sequencing Market was valued at USD 469.36 Million in 2024 and is expected to grow at a CAGR of 4.92% to reach USD 627.03 Million by 2030. The market is gaining momentum due to the expanding application of proteomics in pharmaceutical and biotechnology research. With rising interest in precision medicine, protein sequencing is playing a critical role in decoding disease mechanisms at the molecular level. It is widely used in identifying and validating biomarkers, facilitating the development of targeted therapies. The increasing prevalence of chronic and complex diseases is pushing pharmaceutical firms to adopt advanced sequencing techniques for streamlined drug discovery and development. Furthermore, the integration of protein sequencing into personalized medicine is advancing diagnostics and tailored treatment approaches, reinforcing its significance in healthcare and life sciences.

Key Market Drivers

Surging Demand for Precision Medicine and Biomarker Discovery

The growing demand for precision medicine and biomarker identification is a key factor propelling the Europe Protein Sequencing Market. Precision medicine focuses on tailoring treatment to individual patients based on genetic and molecular profiles, making protein sequencing essential for identifying disease-specific biomarkers. Through detailed analysis of protein structures and functions, sequencing enables the discovery of biomarkers for early diagnosis, monitoring, and targeted therapy—especially for diseases like cancer, cardiovascular disorders, and neurological conditions. The identification of precise biomarkers supports the development of more effective, lower-risk therapies. As a result, significant investments are being made in high-resolution and reproducible sequencing technologies, underscoring protein sequencing’s expanding role in both research and clinical applications.

Key Market Challenges

High Cost of Equipment and Consumables

The high cost of equipment and consumables is a major barrier in the Europe Protein Sequencing Market. Technologies such as mass spectrometry and next-generation sequencing require significant capital investment. The equipment needed for high-throughput protein sequencing is expensive to purchase and maintain, involving costs for servicing, software updates, and skilled personnel. Additionally, consumables like reagents and sequencing chips contribute to recurring expenses, raising the overall cost of experimentation. These financial burdens are especially limiting for small labs and academic institutions with budget constraints, thus hindering broader market adoption and restricting access to protein sequencing technologies.

Key Market Trends

Integration of AI and Machine Learning in Protein Analysis

The integration of artificial intelligence (AI) and machine learning (ML) in protein analysis is an emerging trend driving innovation in the Europe Protein Sequencing Market. AI and ML tools are transforming the way protein data is analyzed, enabling rapid and accurate processing of the vast datasets generated by sequencing technologies. These advanced algorithms improve protein identification, structural prediction, and functional analysis, supporting critical areas such as drug development, disease modeling, and biomarker discovery. By automating data interpretation and identifying complex patterns, AI and ML make protein research more efficient and scalable. They also enhance the precision of predictive models used in personalized medicine and therapeutic targeting, positioning AI-driven sequencing as a cornerstone of next-generation proteomics.

Key Market Players

• Thermo Fisher Scientific
• SCIEX Europe
• Biognosys AG
• Evotec SE
• Sartorius AG
• Proteome Sciences plc
• Biotage AB
• Eurofins Genomics Europe
• Toplab GmbH
• Mass Analytica S.L.

Report Scope:

In this report, the Europe Protein Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Europe Protein Sequencing Market, By Product & Service:
• Protein Sequencing Products

· Reagents & Consumables

· Instruments

· Software

• Protein Sequencing Services
• Europe Protein Sequencing Market, By Application:
• Bio-therapeutics
• Genetic Engineering
• Others
• Europe Protein Sequencing Market, By End User:
• Academic Institutes & Research Centers
• Pharmaceutical & Biotechnology Companies
• Others
• Europe Protein Sequencing Market, By Country:
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Poland
• Bulgaria
• Finland
• Portugal

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Europe Protein Sequencing Market.

Available Customizations:

Europe Protein Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. VOICE OF CUSTOMER

5. EUROPE PROTEIN SEQUENCING MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product & Service (Protein Sequencing Products {Reagents & Consumables, Instruments, Software}, Protein Sequencing Services)
  5.2.2. By Application (Bio-therapeutics, Genetic Engineering, Others)
  5.2.3. By End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Others)
  5.2.4. By Country
  5.2.5. By Company (2024)
5.3. Market Map

6. GERMANY PROTEIN SEQUENCING MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product & Service
  6.2.2. By Application
  6.2.3. By End User

7. FRANCE PROTEIN SEQUENCING MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product & Service
  7.2.2. By Application
  7.2.3. By End User

8. UNITED KINGDOM PROTEIN SEQUENCING MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product & Service
  8.2.2. By Application
  8.2.3. By End User

9. ITALY PROTEIN SEQUENCING MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product & Service
  9.2.2. By Application
  9.2.3. By End User

10. SPAIN PROTEIN SEQUENCING MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product & Service
  10.2.2. By Application
  10.2.3. By End User

11. RUSSIA PROTEIN SEQUENCING MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Product & Service
  11.2.2. By Application
  11.2.3. By End User

12. POLAND PROTEIN SEQUENCING MARKET OUTLOOK

12.1. Market Size & Forecast
  12.1.1. By Value
12.2. Market Share & Forecast
  12.2.1. By Product & Service
  12.2.2. By Application
  12.2.3. By End User

13. BULGARIA PROTEIN SEQUENCING MARKET OUTLOOK

13.1. Market Size & Forecast
  13.1.1. By Value
13.2. Market Share & Forecast
  13.2.1. By Product & Service
  13.2.2. By Application
  13.2.3. By End User

14. FINLAND PROTEIN SEQUENCING MARKET OUTLOOK

14.1. Market Size & Forecast
  14.1.1. By Value
14.2. Market Share & Forecast
  14.2.1. By Product & Service
  14.2.2. By Application
  14.2.3. By End User

15. PORTUGAL PROTEIN SEQUENCING MARKET OUTLOOK

15.1. Market Size & Forecast
  15.1.1. By Value
15.2. Market Share & Forecast
  15.2.1. By Product & Service
  15.2.2. By Application
  15.2.3. By End User

16. MARKET DYNAMICS

16.1. Drivers
16.2. Challenges

17. MARKET TRENDS & DEVELOPMENTS

17.1. Merger & Acquisition (If Any)
17.2. Product Launches (If Any)
17.3. Recent Developments

18. EUROPE PROTEIN SEQUENCING MARKET: SWOT ANALYSIS

19. PORTERS FIVE FORCES ANALYSIS

19.1. Competition in the Industry
19.2. Potential of New Entrants
19.3. Power of Suppliers
19.4. Power of Customers
19.5. Threat of Substitute Products

20. COMPETITIVE LANDSCAPE

20.1. Thermo Fisher Scientific
  20.1.1. Business Overview
  20.1.2. Company Snapshot
  20.1.3. Products & Services
  20.1.4. Financials (As Reported)
  20.1.5. Recent Developments
  20.1.6. Key Personnel Details
  20.1.7. SWOT Analysis
20.2. SCIEX Europe
20.3. Biognosys AG
20.4. Evotec SE
20.5. Sartorius AG
20.6. Proteome Sciences plc
20.7. Biotage AB
20.8. Eurofins Genomics Europe
20.9. Toplab GmbH
20.10. Mass Analytica S.L.

21. STRATEGIC RECOMMENDATIONS

22. ABOUT US & DISCLAIMER